Dr Rama Vancheeswaran

MBBS MSc (Immunology) PhD FRCP

Dr Vancheeswaran (known to almost everyone as 'Rama') trained in Respiratory Medicine following a successful career in medical research, culminating in the award of a PhD from the University of London in 1995. She trained extensively in the investigation and management of complex lung disease, undertaking placements in the Royal Brompton, St Mary's, Harefield and Hammersmith hospitals as part of her post graduate specialist training. 

Following her post graduate training she worked at Barnet hospital and the Royal Free hospital from 2006 to 2018, where she developed a complex Interstitial Lung disease service, a community integrated COPD service, led on the development and running of a sleep medicine service and was Associate Medical Director and Clinical Director for Medicine. 

In 2019 Dr Vancheeswaran moved to West Hertfordshire Hospitals Trust where she continues her interests in general respiratory medicine and Interstitial lung diseases and has worked closely with Dr Matthew Knight and Dr Andrew Barlow on the establishment and evaluation of virtual clinics and improved care for patients with respiratory diseases in the A and E and Acute medicine departments. 

 

 

Dr Vancheeswaran also holds an honoary consultant post at the Royal Brompton hospital in Interstitial Lung diseases and is a member of the British Thoracic Society COPD Specialist Advisory Group. 

Clinical Interests 

  • Interstitial Lung diseases (Idiopathic Pulmonary Fibrosis, Sarcoidosis and other interstitial diseases) 

  • COPD and Asthma 

  • Lung Cancer 

  • Cough and Breathlessness 

  • Clinical hypnosis and psychology of behavioural change in illness- with an interest in smoking cessation and weight loss

  • Recurrent Respiratory Tract infections.  

PUBLICATIONS:

 

Dr Vancheeswaran has been actively involved in medical research in to respiratory and autoimmune disease for over 30 years. As well as being actively involved in both undergraduate and postgraduate teaching she has published extensively. Below are a list of external publications and articles. 

J. Barnett, P.L. Molyneaux, B. Rawal, R. Abdullah, S.S. Hare, R. Vancheeswaran, S.R. Desai, T.M. Maher, A.U. Wells, A. Devaraj. Variable Utility of Mosaic Attenuation to Distinguish Fibrotic Hypersensitivity Pneumonitis from Idiopathic Pulmonary Fibrosis. European Respiratory Journal 2019;

                     

R Abdullah · A N Tavare · A Creamer · D Creer · R Vancheeswaran · S S Hare

Lung cancer tissue diagnosis in poor lung function: Addressing the ongoing percutaneous lung biopsy FEV1 paradox using Heimlich valve. 2016; Thorax

Vancheeswaran R, Huseyin T, McCann N, Allum C. Unexpected variations from the Junior Doctor Strike, May 2016; HSJ

G Greenhall, R Vancheeswaran, ABurns, P Bass, A D Salama. Macrolide Therapy and Alveolar Hemorrhage Secondary to Granulomatosis with Polyangiitis 2015; Journal of Vasculitis

 

A N Tavare · D D Creer · S Khan · R Vancheeswaran · S S Hare

Ambulatory percutaneous lung biopsy with early discharge and Heimlich valve management of iatrogenic pneumothorax: More for less. 2015; Thorax.

H Rahman, P Dupont, M Cohen, R Vancheeswaran. A case of profound hypercalcemia and acute kidney injury. BMJ 2013: 347.

Bloom, CI; Graham, CM; Berry, MPR; Rozakeas, F; Redford, PS; Wang, Y; Xu, Z; Wilkinson, KA; Wilkinson, RJ; Kendrick, Y; Devouassoux, G; Ferry, T; Miyara, M; Bouvry, D; Valeyre, D; Gorochov, G; Blankenship, D; Saadatian, M; Vanhems, P; Beynon, H; Vancheeswaran, R; Wickremasinghe, M; Chaussabel, D; Banchereau, J; Pascual, V; Ho, L-P; Lipman, M and O'Garra, A (2013). Transcriptional blood signatures distinguish pulmonary tuberculosis, pulmonary sarcoidosis, pneumonias and lung cancers. PLOS ONE 8; e70630.

 

Vancheeswaran R, Morgan CM, Wells AU. Pulmonary alveolar proteinosis –investigation and management. A review.  Clinical Pulmonary Medicine. 2006, in press

Hunzelmann N, Risteli J, Risteli L, Sacher C, Vancheeswaran R, Black CM, Krieg T. Circulating type I collagen degradation products: a new serum marker for clinical severity in patients with scleroderma?  Br J Dermatol. 1998 Dec; 139(6):1020-5.

Abraham, DJ, Vancheeswaran, R, Dashwood, MR, Rajkumar, VS, Pantelides, P, Shi-Wen, X, DuBois, RM, Black, CM.  Increased levels of endothelin-1 and differential endothelin type A and B receptor expression in scleroderma-associated fibrotic lung disease. Am J Pathology.  1997, 151(3):  831-841.

Jablonska S, Blaszczyk. Childhood-onset scleroderma from a dermatologist's perspective: comment on the article by Vancheeswaran et al.  Arthritis Rheum. 1997 Jun; 40(6):1183-4.

Vancheeswaran, R, Black C.M, David J, Hasson N, Harper J, Atherton D, Black CM, Woo P. Childhood onset scleroderma. Is it different from adult onset disease?  Arthritis and Rheumatism. 1996; 39 (6): 1041- 1049.

 

Xu SW, Vancheeswaran R, Bou-Gharios G, O'Hare M, Olsen I,  Black CM,  Abraham DJ. Normal human and SSc fibroblasts retain typical phenotypic and functional characteristics following SV40-transfection. Experimental Cell Research. 1995; 220: 407-414.

 

Bruckdorfer KR, Hillary JB, Bunce T, Vancheeswaran R, Black CM. Increased susceptibility to oxidation of low-density lipoproteins isolated from patients with systemic sclerosis. Arthritis Rheum. 1995 Aug; 38(8):1060-7.

 

Gendi NS, Welsh KI, Van Venrooij WJ, Vancheeswaran R, Gilroy J, Black CM. HLA type as a predictor of mixed connective tissue disease differentiation. Ten-year clinical and immunogenetic followup of 46 patients. Arthritis Rheum. 1995 Feb; 38(2):259-66.

 

Bou-Gharios G, Osman J, Atherton A, Monaghan P, Vancheeswaran R, Black CM, Olsen IO. Expression of ectopeptidases in scleroderma. Ann Rheum Dis. 1995 Feb; 54(2):111-6.

 

Shi-Wen X, Panesar M, Vancheeswaran R, Mason J, Haskard DO, Black CM, Olsen IO, Abraham DJ.  Expression and shedding of ICAM-1 and LFA-3 by SSc and normal fibroblasts. Arthritis and Rheumatism. 1994; 37: 1689-1697

 

Vancheeswaran R, Magoulas T, Efrat G, Penny RM, Black CM.  Circulating endothelin-1 levels suggest different pathogenic mechanisms in systemic sclerosis (SSc) subsets.  Journal of Rheumatology 1994; 21:1838-1844

 

Vancheeswaran R, Azam A, Black CM, Dashwood MR.  Localisation of endothelin-1 and its binding sites in scleroderma skin. Journal of Rheumatology 1994; 21: 1268-1276

 

Higley H, Persichitte K, Chu S, Waegell W, Vancheeswaran R, Black CM. Immunocytochemical localization and serologic detection of transforming growth factor beta 1. Association with type I procollagen and inflammatory cell markers in diffuse and limited systemic sclerosis, morphea, and Raynaud's phenomenon. Arthritis Rheum. 1994 Feb; 37(2):278-88.

 

Stevens W, Vancheeswaran R, Black CM.  Alpha interferon (Roferon-A) in the treatment of diffuse systemic sclerosis: A pilot study. Br. J. Rheum. 31: 683-689, 1992.

 

Endeley EM, Patel RV, Vancheeswaran R.  Hydatid disease of spleen treated by cyst enucleation and splenic salvage. J Pediatr Surg. 1988 May; 23(5):506.

© 2019. The Chest Clinic.

  • Twitter Clean